Sheller, P.C. Attorney Brian J. McCormick comments on whether recent verdicts of $1.5+ billion will influence Johnson and Johnson policy and ultimately affect consumers.

PARSIPPANY, N.J., Feb. 8, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc.

FORT WASHINGTON, Pa., Sept. 28, 2011 /PRNewswire/ -- McNEIL-PPC, Inc.

BALTIMORE, Aug. 31, 2011 /PRNewswire/ -- Lupin Pharmaceuticals, Inc.

BEERSE, Belgium, July 7, 2011 /PRNewswire/ -- Janssen Pharmaceutica NV, part of the Janssen Pharmaceutical Companies, today announced it has completed the divestiture of its Animal Health business to Elanco, a Division of Eli Lilly and Company.